Literature DB >> 2308028

3-Hydroxydicarboxylic aciduria--a fatty acid oxidation defect with severe prognosis.

L Hagenfeldt1, U von Döbeln, E Holme, J Alm, G Brandberg, E Enocksson, L Lindeberg.   

Abstract

We describe five patients with a suspected defect in the beta-oxidation of fatty acids characterized by a massive excretion of 3-hydroxydicarboxylic acids in the urine and accumulation of 3-hydroxy fatty acids in serum during acute illness. Long-chain and medium-chain acyl-coenzyme A dehydrogenases in fibroblasts were normal in all patients. Four of them died of cardiomyopathy and liver insufficiency at 3 to 14 months of age. Two of the patients had elder siblings who had died unexpectedly in early infancy. These patients differ from previously described patients with beta-oxidation defects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308028     DOI: 10.1016/s0022-3476(05)82826-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  22 in total

1.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  H Przyrembel; C Jakobs; L IJlst; J B de Klerk; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis.

Authors:  Kashan Ahmed; Sorin Tunaru; Claus-Dieter Langhans; Julien Hanson; Christoph W Michalski; Stefan Kölker; Patricia M Jones; Jürgen G Okun; Stefan Offermanns
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

3.  Lethal dilated cardiomyopathy due to long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  E Martins; A Costa; E Silva; M Medina; M L Cardoso; C Vianey-Saban; P Divry; L Vilarinho
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Hypoketonuric 3-hydroxydicarboxylic aciduria in five patients with glycogen storage disease.

Authors:  C E Mize; L J Waber; T Anderson; M J Bennett
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

5.  Growth in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.

Authors:  C Bieneck Haglind; M Halldin Stenlid; S Ask; J Alm; A Nemeth; Uv Döbeln; A Nordenström
Journal:  JIMD Rep       Date:  2012-07-06

6.  Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.

Authors:  J J Shen; D Matern; D S Millington; S Hillman; M D Feezor; M J Bennett; M Qumsiyeh; S G Kahler; Y T Chen; J L Van Hove
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

7.  Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.

Authors:  C Bieneck Haglind; A Nordenström; S Ask; U von Döbeln; J Gustafsson; M Halldin Stenlid
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

8.  Marked elevation of urinary 3-hydroxydecanedioic acid in a malnourished infant with glycogen storage disease, mimicking long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  J Bergoffen; P Kaplan; D E Hale; M J Bennett; G T Berry
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  Fatty acid oxidation in fibroblasts from patients with defects in beta-oxidation and in the respiratory chain.

Authors:  N Venizelos; U von Döbeln; L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

10.  Acute dilated cardiomyopathy in a patient with deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase.

Authors:  Peter C Dyke; Laura Konczal; Dennis Bartholomew; Kim L McBride; Timothy M Hoffman
Journal:  Pediatr Cardiol       Date:  2008-12-16       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.